Science ❯Research ❯Pharmacology

Drug Development

Clinical Trials

Nonhallucinogenic Tabernanthalog Drives Antidepressant Plasticity Without Glutamate Surges

TBG’s partial engagement of the serotonin 2A receptor drives dendritic spine formation necessary for lasting antidepressant-like effects in rodents.

Dual Enzyme Inhibitors Convert Neuroblastoma Tumors into Healthy Neurons in Mice